feed,title,long_url,short_url
Benzinga,GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma,https://benzinga.com/general/biotech/24/06/39144773/gsks-blenrep-combo-therapy-cuts-risk-of-disease-progression-or-death-by-around-50-in-pretreated-m,https://da.gd/v8xgdM
